SOLARA NSE filing

Solara Active Pharma Sciences Receives Rectification Order, Tax Demand of ₹161.92 Crore Dropped

The RealCase readMedium impact Positive

Solara Active Pharma Sciences received a Rectification Order from the Income Tax Department on August 08, 2026. The order rectifies a previous tax demand of ₹161.92 Crore, reducing it to Nil. This has no financial or operational impact on the company.

Why it matters

The dropping of a ₹161.92 Crore tax demand is a material development for the company, although it does not immediately alter financials or operations as the demand was based on an incorrect computation.

The market read

The company received a favorable rectification order from the Income Tax Department, which dropped a significant tax demand, positively impacting the company's financial standing.

Solara Active Pharma Sciences Limited has announced the receipt of a Rectification Order under Section 154 read with Section 147 of the Income Tax Act, 1961, from the Assistant Commissioner of Income Tax, Central Circle 3, Thane. This order rectifies an error in the tax computation related to a Demand Notice received on March 17, 2026. The company had previously filed an application for rectification, stating that the tax demand of ₹161.92 Crore was incorrectly computed.

Consequently, the Rectification Order has dropped the tax demand to Nil. The company has confirmed that there is no pending demand on the company, and there is no impact on its financials, operations, or other activities as a result of this order. The rectification order does not identify any aberrations, non-compliance, violations, or defaults on the part of the company, and no penalty or restriction has been imposed.

The company had initially disclosed the details of the Demand Notice on March 18, 2026. The Rectification Order was received by the company on August 08, 2026, pertaining to Assessment Year 2019-20. This information will also be available on the company's website.

Primary source

A plain-language summary of a public exchange filing by Solara Active Pharma Sciences Limited. Read the original for the full detail.

View original filing
This is RealCase

Every move, explained.

Expert model portfolios with exact weights, an Active or Hold state on every holding, and a written reason behind every change. In your pocket.

Coming soon toApp StoreComing soon toGoogle Play
100% digital · your money stays in your own broker · your data is secure
RealCase
Your RealCases
Core Compounders
Stocks
13.4%
Flexi Core
Mutual Funds
13.1%
Latest change
ActiveHDFC Bank10% → 14%

“Deposits growing faster than loans again. We add on strength, funded from cash.”

₹0Commission · fee-only